4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-078814
Corporate Controller & CAO sold 1,500 shares at $95.00 ($142,500)
- Corporate Controller & CAO acquired 1,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| German Christopher Paul Corporate Controller & CAO | 2025-08-12 | Option exercise 10b5-1 | +1,000 | $17.97 | $17,970 | 1,922 | D |
| German Christopher Paul Corporate Controller & CAO | 2025-08-12 | Option exercise 10b5-1 | +500 | $49.23 | $24,615 | 1,422 | D |
| German Christopher Paul Corporate Controller & CAO | 2025-08-12 | Sale 10b5-1 | −1,500 | $95.00 | $142,500 | 922 | D |
| Derivatives | |||||||
| German Christopher Paul Corporate Controller & CAO | 2025-08-12 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −1,000 | 5,231 | D | ||
| German Christopher Paul Corporate Controller & CAO | 2025-08-12 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −500 | 4,050 | D | ||
| Open-market sales · 1,500 sh · avg $95.00 · $142,500 | |||||||
Loading xslF345X05/tm2523328-2_4seq1.xml…